Stay updated on Elsubrutinib & Upadacitinib in SLE Clinical Trial
Sign up to get notified when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.

Latest updates to the Elsubrutinib & Upadacitinib in SLE Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedThe page history now includes a new entry: Revision: v3.3.3. The HHS Vulnerability Disclosure and the Revision: v3.3.2 entries were removed.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page revision label was updated from v3.3.1 to v3.3.2 on the Record History page, with no changes to study data or content. No significant content updates were observed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedIn the record history, the revision is updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange DetectedRemoved the government funding/operating-status disclaimer that warned about potential delays and directed users to cc.nih.gov and opm.gov.SummaryDifference0.4%

- Check67 days agoChange DetectedA new version dated 2023-06-27 updates multiple core sections including Study Status, Study Description, Arms and Interventions, Outcome Measures, Eligibility, Contacts/Locations, Document Section, and IPD Sharing.SummaryDifference0.1%

- Check96 days agoChange DetectedPage now includes an official operating-status notice and updates version to v3.2.0, replacing v3.1.0.SummaryDifference9%

Stay in the know with updates to Elsubrutinib & Upadacitinib in SLE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.